NFE2L2 and renal cell carcinoma: The NRF2-ARE signature, which was initially characterized in PRCCs, has been recently reported to be altered in 3.2% of ccRCCs [14], becoming one of the molecular alterations that manifests transversally among RCC histological subtypes.